Wilson Sonsini Goodrich & Rosati advised Versant Ventures and OrbiMed on the transaction.Helicore Biopharma, a biopharmaceutical company focused on the discovery and development of first-in-class glucose-dependent…
Helicore Biopharma’s $65 Million Series A Financing Round
